
Neovasc NVCN
Annual report 2021
added 12-23-2023
Neovasc EBITDA per Share 2011-2026 | NVCN
Annual EBITDA per Share Neovasc
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.49 | -5.4 | -4.61 | -22.9 | -379 | -2.01 K | -331 | -314 | -132 | -97.3 | -93.7 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -0.49 | -2.01 K | -308 |
EBITDA per Share of other stocks in the Medical devices industry
| Issuer | EBITDA per Share | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Aziyo Biologics
AZYO
|
-1.47 | - | 1.37 % | $ 20.5 M | ||
|
GenMark Diagnostics, Inc.
GNMK
|
-1.24 | - | - | $ 1.77 B | ||
|
Conformis
CFMS
|
-5.85 | - | - | $ 16.4 M | ||
|
Bruker Corporation
BRKR
|
2.93 M | $ 39.26 | -0.03 % | $ 5.85 K | ||
|
Lianluo Smart Limited
LLIT
|
2.46 | - | 24.59 % | $ 44.8 M | ||
|
Cardiovascular Systems
CSII
|
-0.82 | - | 0.15 % | $ 844 M | ||
|
Cutera
CUTR
|
-7.45 | - | -10.19 % | $ 1.99 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
-0.341 | - | -5.86 % | $ 30.6 M | ||
|
Acutus Medical
AFIB
|
-0.4 | - | -26.83 % | $ 2.62 M | ||
|
Dynatronics Corporation
DYNT
|
-0.24 | - | 14.99 % | $ 929 K | ||
|
Eargo
EAR
|
-26.8 | - | - | $ 10.2 M | ||
|
Cognyte Software Ltd.
CGNT
|
0.12 | $ 8.01 | 2.43 % | $ 575 M | ||
|
Allied Healthcare Products
AHPI
|
-0.2 | - | 3.58 % | $ 2.21 M | ||
|
Second Sight Medical Products
EYES
|
-442 | - | -0.97 % | $ 54.4 M | ||
|
AdaptHealth Corp.
AHCO
|
3.5 | $ 9.63 | 2.39 % | $ 1.3 B | ||
|
Apollo Endosurgery
APEN
|
-0.74 | - | - | $ 475 M | ||
|
EDAP TMS S.A.
EDAP
|
-0.48 | $ 4.17 | 4.51 % | $ 155 M | ||
|
CONMED Corporation
CNMD
|
3.86 | $ 43.47 | 0.36 % | $ 1.35 B | ||
|
Electromed
ELMD
|
1.27 | $ 24.2 | 0.92 % | $ 205 M | ||
|
CryoLife, Inc.
CRY
|
0.827 | - | -4.14 % | $ 702 M | ||
|
Avinger
AVGR
|
-20.8 | - | -20.74 % | $ 369 K | ||
|
CHF Solutions, Inc.
CHFS
|
-0.207 | - | 1.15 % | $ 34.5 M | ||
|
AxoGen
AXGN
|
-0.03 | $ 29.57 | -0.87 % | $ 1.36 B | ||
|
Apyx Medical Corporation
APYX
|
-0.48 | $ 3.22 | 1.58 % | $ 111 M | ||
|
Axonics Modulation Technologies
AXNX
|
-1.14 | - | - | $ 3.31 B | ||
|
FONAR Corporation
FONR
|
1.5 | $ 18.55 | 0.27 % | $ 122 M | ||
|
Soliton, Inc.
SOLY
|
-0.544 | - | -1.42 % | $ 435 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
7.59 | - | -1.98 % | $ 98.3 M | ||
|
Itamar Medical Ltd.
ITMR
|
0.999 | - | 0.03 % | $ 1.58 B | ||
|
Accuray Incorporated
ARAY
|
0.14 | $ 0.52 | -1.73 % | $ 53.4 M | ||
|
Misonix, Inc.
MSON
|
-0.2 | - | - | $ 462 M | ||
|
Medigus Ltd.
MDGS
|
-0.181 | - | 10.28 % | $ 55.5 M | ||
|
Cytosorbents Corporation
CTSO
|
-0.28 | $ 0.79 | -1.52 % | $ 43 M | ||
|
Align Technology
ALGN
|
10.1 | $ 183.62 | 0.54 % | $ 13.7 B | ||
|
Intersect ENT, Inc.
XENT
|
-1.79 | - | - | $ 955 M | ||
|
Inari Medical
NARI
|
-0.44 | - | - | $ 4.23 B | ||
|
Butterfly Network
BFLY
|
-0.31 | $ 3.94 | 6.35 % | $ 834 M | ||
|
BIOLASE
BIOL
|
-11.8 | - | -13.19 % | $ 166 K | ||
|
Abbott Laboratories
ABT
|
5.45 | $ 113.39 | -0.17 % | $ 197 B | ||
|
NuVasive
NUVA
|
2.83 | - | - | $ 2.07 B | ||
|
Nevro Corp.
NVRO
|
-3.19 | - | - | $ 217 M | ||
|
BioSig Technologies
BSGM
|
-0.9 | - | 37.08 % | $ 85.7 M | ||
|
Boston Scientific Corporation
BSX
|
3.36 | $ 72.39 | -1.98 % | $ 107 B | ||
|
InMode Ltd.
INMD
|
1.33 | $ 13.53 | -0.51 % | $ 874 M | ||
|
Helius Medical Technologies
HSDT
|
-20.4 | $ 2.14 | 8.08 % | $ 1.3 M | ||
|
Alphatec Holdings
ATEC
|
-0.03 | $ 12.99 | -0.23 % | $ 1.95 B | ||
|
IRIDEX Corporation
IRIX
|
-0.55 | $ 1.42 | -0.7 % | $ 22.9 M | ||
|
IRadimed Corporation
IRMD
|
1.8 | $ 105.43 | 1.09 % | $ 1.34 B | ||
|
Edwards Lifesciences Corporation
EW
|
2.43 | $ 85.35 | 0.1 % | $ 49.9 B |